Skip to main content
. 2021 Mar 23;3(4):100352. doi: 10.1016/j.ajogmf.2021.100352

Table 2.

Perspectives on SARS-CoV-2 vaccine of the included women (Questionnaire Part B)

Questions Answers n (%)
Agreement to be vaccinated against SARS-CoV-2 Yes
No
40 (28.2)
102 (71.8)
Feeling safe about SARS-CoV-2 vaccine Totally insecure
Rather insecure
Safe enough
Totally safe
34 (23.9)
69 (48.6)
39 (27.5)
0
Being pregnant influence the choice Yes
No
99 (69.7)
43 (30.3)
Usually in favor of vaccines Yes
No
128 (90.1)
14 (9.9)
Received or would receive other vaccine during pregnancy (DTaP and/or influenza) Yes
No
75 (52.8)
67 (47.2)

Data are presented as number (percentage).

DTaP, diphtheria, tetanus, and acellular pertussis; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Carbone. SARS-CoV-2 vaccine and pregnancy. Am J Obstet Gynecol MFM 2021.